Mizuho Lowers its Price Target on Phreesia (PHR) to $19

Phreesia, Inc. (NYSE:PHR) is one of the 10 Small–Cap Stocks Insiders Are Buying Recently.

On March 24, 2026, Mizuho analyst Steven Valiquette lowered the price target on Phreesia, Inc. (NYSE:PHR) to $19 from $22 previously and maintained an Outperform rating ahead of the company’s fiscal Q4 report on March 30. Steven Valiquette said the firm is taking a more conservative approach to estimates following peer earnings reports.

On March 16, 2026, Phreesia, Inc. (NYSE:PHR) announced it refinanced its existing bridge loan by entering into a new credit agreement for a senior secured revolving credit facility of up to $275M, with Capital One serving as agent. The company borrowed about $92.2M at closing to repay all outstanding obligations under the bridge loan, which was terminated without penalty, and said remaining capacity may be used for working capital, capital expenditures, acquisitions, and other general corporate purposes.

Mizuho Lowers its Price Target on Phreesia (PHR) to $19

15 States with the Best Healthcare in the US

Last month, JPMorgan analyst Alexei Gogolev lowered the price target on Phreesia, Inc. (NYSE:PHR) to $24 from $29 previously and maintained an Overweight rating.

Phreesia, Inc. (NYSE:PHR) provides a SaaS-based software and payment platform for healthcare providers in North America.

While we acknowledge the risk and potential of PHR as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than PHR and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years.

Disclosure: None.  Follow Insider Monkey on Google News.